Home / News / India News / Article /
WHO recommends Malaria vaccine made by Oxford University and SII
Updated On: 03 October, 2023 08:41 AM IST | Pune | ANI
The Phase III trial results are under peer review before publication.
Listen to this article :
World Health Organisation. Pic/AFP
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards. Following a rigorous, detailed scientific review by the WHO`s independent advisory body, the Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG), the R21/Matrix-M malaria vaccine has been recommended for use.
`The recommendation was based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission, making it the world`s second-ever WHO recommended vaccine for preventing malaria in children,` Serum Institute of India said in a statement.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT